{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:30:24Z","timestamp":1786375824338,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PIA\/ANR-11-INSB-005"],"award-info":[{"award-number":["PIA\/ANR-11-INSB-005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008222","name":"Universit\u00e9 de Montpellier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.joca.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:14:28Z","timestamp":1703852068000},"page":"634-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["What is the rationale for mesenchymal stromal cells based therapies in the management of hemophilic arthropathies?"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-4903","authenticated-orcid":false,"given":"Alexandre","family":"Th\u00e9ron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Biron-Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.joca.2023.12.007_bib1","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.joca.2023.12.007_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/hae.14247","article-title":"Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders","volume":"27","author":"Aquino","year":"2021","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2516.2010.02472.x","article-title":"Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia","volume":"17","author":"Dunn","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl 4","key":"10.1016\/j.joca.2023.12.007_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01732.x","article-title":"Physiopathology of haemophilic arthropathy","volume":"14","author":"Lafeber","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib6","first-page":"297","article-title":"Alterations in chondrocyte morphology, proliferation and binding of 35SO4 due to Fe(III), Fe(II), ferritin and haemoglobin in vitro","volume":"38","author":"Kirkpatrick","year":"1982","journal-title":"Virchows Arch\u00a0B\u00a0Cell Pathol"},{"issue":"6","key":"10.1016\/j.joca.2023.12.007_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.20284","article-title":"Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy","volume":"50","author":"Hooiveld","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.joca.2023.12.007_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/keg220","article-title":"Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study","volume":"42","author":"Hooiveld","year":"2003","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib9","first-page":"339","article-title":"Blood-induced joint damage: longterm effects in vitro and in vivo","volume":"30","author":"Hooiveld","year":"2003","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib10","first-page":"275","article-title":"Ultrastructural appearance of human synovial membrane in the reabsorption phase of acute haemarthrosis","volume":"6","author":"Letizia","year":"1980","journal-title":"Ital J Orthop Traumatol"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib11","first-page":"173","article-title":"Haemarthrosis stimulates the synovial fibrinolytic system in haemophilic mice","volume":"110","author":"Nieuwenhuizen","year":"2013","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/BST20200672","article-title":"Musculoskeletal complications associated with pathological iron toxicity and its molecular mechanisms","volume":"49","author":"Sim\u00e3o","year":"2021","journal-title":"Biochem Soc Trans"},{"issue":"19","key":"10.1016\/j.joca.2023.12.007_bib13","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2015-03-635524","article-title":"IL-1\u03b2, in contrast to TNF\u03b1, is pivotal in blood-induced cartilage damage and is a potential target for therapy","volume":"126","author":"van Vulpen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.joca.2023.12.007_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00541","article-title":"Pathophysiological role of synovitis in hemophilic arthropathy development: a two-hit hypothesis","volume":"11","author":"Calcaterra","year":"2020","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.joca.2023.12.007_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm6070063","article-title":"Pathophysiology of hemophilic arthropathy","volume":"6","author":"Melchiorre","year":"2017","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.joca.2023.12.007_bib16","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2010-05-284653","article-title":"Neoangiogenesis contributes to the development of hemophilic synovitis","volume":"117","author":"Acharya","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/hae.13236","article-title":"Differential effects of bleeds on the development of arthropathy - basic and applied issues","volume":"23","author":"van Vulpen","year":"2017","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.1999.00608.x","article-title":"Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease","volume":"34","author":"Roosendaal","year":"1999","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/jth.12113","article-title":"Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study","volume":"11","author":"Hilliard","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"17","key":"10.1016\/j.joca.2023.12.007_bib20","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood-2016-02-683169","article-title":"Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project","volume":"129","author":"Manco-Johnson","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/hae.14451","article-title":"Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3-decade retrospective review","volume":"28","author":"Lin","year":"2022","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/hae.14766","article-title":"The humanistic and economic burden of problem joints for children and adults with moderate or severe haemophilia A: Analysis of the CHESS population studies","volume":"29","author":"Chowdary","year":"2023","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib23","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1111\/hae.13166","article-title":"Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden","volume":"23","author":"Osooli","year":"2017","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/jth.15676","article-title":"Joint status of patients with nonsevere hemophilia A","volume":"20","author":"Zwagemaker","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1160\/TH10-07-0492","article-title":"High incidence of ankle arthropathy in mild and moderate haemophilia A","volume":"105","author":"Ling","year":"2011","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.joca.2023.12.007_bib26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.14242","article-title":"Nano-evidence for joint microbleeds in hemophilia patients","volume":"16","author":"Puetz","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/hae.13201","article-title":"Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors\u2019 Organisation (UKHCDO) guideline","volume":"23","author":"Hanley","year":"2017","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.joca.2023.12.007_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/hae.14633","article-title":"Ankle joint distraction is a promising alternative treatment for patients with severe haemophilic ankle arthropathy","volume":"28","author":"van Bergen","year":"2022","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/hae.14784","article-title":"Structural changes after ankle joint distraction in haemophilic arthropathy: an explorative study investigating biochemical markers and 3D joint space width","volume":"29","author":"van Bergen","year":"2023","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41584-021-00695-y","article-title":"Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms","volume":"18","author":"Jansen","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2516.2007.01518.x","article-title":"European study on orthopaedic status of haemophilia patients with inhibitors","volume":"13","author":"Morfini","year":"2007","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17474086.2019.1602035","article-title":"Risks and patient outcomes of surgical intervention for hemophilic arthropathy","volume":"12","author":"Rodriguez-Merchan","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"1S Suppl 1","key":"10.1016\/j.joca.2023.12.007_bib33","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MBC.0000000000000824","article-title":"Surgical approaches to hemophilic arthropathy","volume":"30","author":"Rodriguez-Merchan","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jth.12467","article-title":"Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice","volume":"12","author":"Nieuwenhuizen","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/hae.12770","article-title":"Silencing of protease-activated receptors attenuates synovitis and cartilage damage following a joint bleed in haemophilic mice","volume":"22","author":"Nieuwenhuizen","year":"2016","journal-title":"Haemophilia"},{"issue":"Suppl 4","key":"10.1016\/j.joca.2023.12.007_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2012.02835.x","article-title":"Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond","volume":"18","author":"Forsyth","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.12148","article-title":"A single intra-articular injection with IL-4 plus IL-10 ameliorates blood-induced cartilage degeneration in haemophilic mice","volume":"160","author":"van Meegeren","year":"2013","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.joca.2023.12.007_bib38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/ket005","article-title":"A short time window to profit from protection of blood-induced cartilage damage by IL-4 plus IL-10","volume":"52","author":"van Meegeren","year":"2013","journal-title":"Rheumatology ((Oxford))"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jth.12176","article-title":"IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia","volume":"11","author":"Narkbunnam","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/jcm9010075","article-title":"A translational study of TNF-alpha antagonists as an adjunctive therapy for preventing hemophilic arthropathy","volume":"9","author":"Zhang","year":"2019","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.joca.2023.12.007_bib41","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00402-009-0885-x","article-title":"Preventing blood-induced joint damage with the use of intra-articular iron chelators: an experimental study in rabbits","volume":"129","author":"Kocao\u011flu","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib42","first-page":"1044","article-title":"Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice","volume":"112","author":"Nieuwenhuizen","year":"2014","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib43","first-page":"257","article-title":"The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture","volume":"110","author":"Anagnostis","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.joca.2023.12.007_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00997","article-title":"Mesenchymal stem cell-derived extracellular vesicles: opportunities and challenges for clinical translation","volume":"8","author":"Maumus","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"10","key":"10.1016\/j.joca.2023.12.007_bib47","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/kep162","article-title":"Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?","volume":"48","author":"Bouffi","year":"2009","journal-title":"Rheumatology ((Oxford))"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib48","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","article-title":"Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis","volume":"56","author":"Augello","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2008.03683.x","article-title":"Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice","volume":"153","author":"Choi","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.joca.2023.12.007_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014247","article-title":"IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis","volume":"5","author":"Bouffi","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.joca.2023.12.007_bib51","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/art.39069","article-title":"Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis: GILZ-mediated therapeutic potential of MSCs","volume":"67","author":"Luz-Crawford","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.joca.2023.12.007_bib52","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cells9081852","article-title":"Mesenchymal stem\/stromal cells for rheumatoid arthritis treatment: an update on clinical applications","volume":"9","author":"Lopez-Santalla","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/14712598.2016.1093108","article-title":"Therapeutic application of mesenchymal stem cells in osteoarthritis","volume":"16","author":"Ruiz","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/17460751.1.4.529","article-title":"Engineered mesenchymal stem cells for cartilage repair","volume":"1","author":"Djouad","year":"2006","journal-title":"Regen Med"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib55","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar2153","article-title":"Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes","volume":"9","author":"Djouad","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib56","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.scr.2013.05.008","article-title":"Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis","volume":"11","author":"Maumus","year":"2013","journal-title":"Stem Cell Res"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib57","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.37908","article-title":"Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2","volume":"65","author":"Manferdini","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.joca.2023.12.007_bib58","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1002\/art.34626","article-title":"Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis","volume":"64","author":"ter Huurne","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.39425","article-title":"Inhibition of osteoarthritis by adipose-derived stromal cells overexpressing Fra-1 in mice: Fra-1-transgenic mouse ADSCs protect against OA","volume":"68","author":"Schwabe","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2023.12.007_bib60","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fimmu.2016.00392","article-title":"Utility of a mouse model of osteoarthritis to demonstrate cartilage protection by IFN\u03b3-primed equine mesenchymal stem cells","volume":"7","author":"Maumus","year":"2016","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.joca.2023.12.007_bib61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5966\/sctm.2015-0245","article-title":"Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial","volume":"5","author":"Pers","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.joca.2023.12.007_bib62","first-page":"121","article-title":"Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis","volume":"24","author":"Song","year":"2020","journal-title":"J\u00a0Orthop\u00a0Transl"},{"key":"10.1016\/j.joca.2023.12.007_bib63","article-title":"Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases","volume":"106","author":"Huldani","year":"2022","journal-title":"Int\u00a0Immunopharmacol"},{"issue":"9","key":"10.1016\/j.joca.2023.12.007_bib64","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/sctm.19-0446","article-title":"The emerging antioxidant paradigm of mesenchymal stem cell therapy","volume":"9","author":"Stavely","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.joca.2023.12.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2019.07.026","article-title":"Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects","volume":"143","author":"Xia","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.joca.2023.12.007_bib66","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41584-023-01010-7","article-title":"Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells","volume":"19","author":"Bertolino","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1 Suppl 1","key":"10.1016\/j.joca.2023.12.007_bib67","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1097\/TA.0000000000001485","article-title":"Procoagulant activity of human mesenchymal stem cells","volume":"83","author":"Christy","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"1S Suppl 1","key":"10.1016\/j.joca.2023.12.007_bib68","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1097\/TA.0000000000002225","article-title":"The effects of cell type and culture condition on the procoagulant activity of human mesenchymal stromal cell-derived extracellular vesicles","volume":"87","author":"Chance","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"10.1016\/j.joca.2023.12.007_bib69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/sctm.18-0015","article-title":"Clinical cellular therapeutics accelerate clot formation","volume":"7","author":"George","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.joca.2023.12.007_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/sctm.19-0206","article-title":"Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population","volume":"9","author":"George","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.joca.2023.12.007_bib71","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/sctm.20-0454","article-title":"Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application","volume":"10","author":"O\u2019Rourke","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"5 Pt 1","key":"10.1016\/j.joca.2023.12.007_bib72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1538-7836.2004.00552.x","article-title":"Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice","volume":"2","author":"Brown","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.joca.2023.12.007_bib74","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1182\/blood-2005-12-4961","article-title":"High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells","volume":"107","author":"Gangadharan","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.joca.2023.12.007_bib75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jgg.2013.11.002","article-title":"The mesenchymal stem cells derived from transgenic mice carrying human coagulation factor VIII can correct phenotype in hemophilia A mice","volume":"40","author":"Wang","year":"2013","journal-title":"J Genet Genomics"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/hum.2012.162","article-title":"Genetically modified adipose tissue-derived stem\/stromal cells, using simian immunodeficiency virus-based lentiviral vectors, in the treatment of hemophilia B","volume":"24","author":"Watanabe","year":"2013","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.joca.2023.12.007_bib77","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3892\/mmr.2017.6131","article-title":"Targeted introduction and effective expression of hFIX at the AAVS1 locus in mesenchymal stem cells","volume":"15","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.joca.2023.12.007_bib78","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1907","article-title":"Preliminary study on non-viral transfection of F9 (factor IX) gene by nucleofection in human adipose-derived mesenchymal stem cells","volume":"4","author":"Olmedillas L\u00f3pez","year":"2016","journal-title":"PeerJ"},{"issue":"2","key":"10.1016\/j.joca.2023.12.007_bib79","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4274\/tjh.galenos.2023.2022.0318","article-title":"In vitro FVIII encoding transgenic mesenchymal stem cells maintain a successful coagulation in FVIII- deficient plasma mimicking hemophilia A","volume":"40","author":"Hem\u015finlio\u011flu","year":"2023","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.joca.2023.12.007_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630353","article-title":"Restoration of FVIII function and phenotypic rescue in hemophilia a mice by transplantation of MSCs derived from F8-modified iPSCs","volume":"9","author":"Qiu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0963689717728937","article-title":"In utero transplantation of placenta-derived mesenchymal stromal cells for potential fetal treatment of hemophilia A","volume":"27","author":"Kumar","year":"2018","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1138-8","article-title":"Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells","volume":"10","author":"Gao","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.joca.2023.12.007_bib83","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1538-7836.2012.04851.x","article-title":"Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice","volume":"10","author":"Kashiwakura","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.joca.2023.12.007_bib84","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1111\/jcmm.13648","article-title":"Durable engraftment of genetically modified FVIII-secreting autologous bone marrow stromal cells in the intramedullary microenvironment","volume":"22","author":"Lee","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.joca.2023.12.007_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070476","article-title":"Autologous bone marrow-derived MSCs engineered to express oFVIII-FLAG engraft in adult sheep and produce an effective increase in plasma FVIII levels","volume":"13","author":"Trevisan","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biomaterials.2010.08.094","article-title":"Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B","volume":"32","author":"Coutu","year":"2011","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.joca.2023.12.007_bib87","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.3390\/ijms23137282","article-title":"In vitro conditioning of adipose-derived mesenchymal stem cells by the endothelial microenvironment: modeling cell responsiveness towards non-genetic correction of haemophilia A","volume":"23","author":"Barbon","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.joca.2023.12.007_bib88","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/TP.0000000000001773","article-title":"Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia A patient","volume":"101","author":"Sokal","year":"2017","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib89","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/hae.12659","article-title":"Experimental study on the role of intra-articular injection of MSCs on cartilage regeneration in haemophilia","volume":"21","author":"Ravanbod","year":"2015","journal-title":"Haemophilia"},{"issue":"12","key":"10.1016\/j.joca.2023.12.007_bib90","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.exphem.2011.09.001","article-title":"Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC","volume":"39","author":"Porada","year":"2011","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.joca.2023.12.007_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000924","article-title":"Mesenchymal stromal cells prevent blood-induced degeneration of chondrocytes in a new model of murine hemarthrosis","volume":"7","author":"Th\u00e9ron","year":"2023","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.joca.2023.12.007_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15376-8","article-title":"Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis","volume":"7","author":"Cosenza","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.joca.2023.12.007_bib93","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.7150\/thno.21072","article-title":"Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis","volume":"8","author":"Cosenza","year":"2018","journal-title":"Theranostics"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458423010221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458423010221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:06:28Z","timestamp":1786374388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458423010221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1063458423010221"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2023.12.007","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the rationale for mesenchymal stromal cells based therapies in the management of hemophilic arthropathies?","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}